Comparative efficacy and safety of immunotherapy for patients with advanced or metastatic esophageal squamous cell carcinoma: a systematic review and network Meta-analysis

BACKGROUND: The study aimed to compare efficacy and safety of various immune checkpoint inhibitors for patients with advanced or metastatic esophageal squamous cell carcinoma (ESCC). METHODS: We searched Medline, Web of Science, Cochrane Central Register of Controlled Trials, Embase, Clinical Trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Tian-Tian, Shan, Jia-Hui, Yang, Yu-Xian, Zhang, Ze-Wei, Liu, Shi-Liang, Xi, Mian, Liu, Meng-Zhong, Zhao, Lei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482734/
https://www.ncbi.nlm.nih.gov/pubmed/36115960
http://dx.doi.org/10.1186/s12885-022-10086-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9482734/
https://www.ncbi.nlm.nih.gov/pubmed/36115960
http://dx.doi.org/10.1186/s12885-022-10086-5

Ejemplares similares